Company Filing History:
Years Active: 2024
Title: Myeong Joon Kim: Innovator in Cancer Therapeutics
Introduction
Myeong Joon Kim is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of cancer therapeutics through his innovative research and development.
Latest Patents
Myeong Joon Kim holds a patent for an "Anti-B7-H3 antibody and use thereof." This invention provides an anti-B7-H3 antibody that specifically recognizes B7-H3, which can be effectively utilized as a cancer therapeutic agent. The antibody exhibits inhibitory activity of an immune checkpoint, inducing antibody-dependent cell-mediated cytotoxicity and T cell activation that is inhibited by B7-H3. This antibody can be used in combination with other immunoantibody therapeutic agents and is beneficial for cancer targeting treatment, including the detection of various cancers expressing B7-H3 through specific binding and drug delivery to specific cancer types.
Career Highlights
Myeong Joon Kim is associated with Abl Bio Inc., where he continues to advance his research in cancer therapies. His work is pivotal in developing innovative solutions for cancer treatment.
Collaborations
He collaborates with notable colleagues, including Kyeongsu Park and Yangsoon Lee, contributing to a dynamic research environment focused on cancer therapeutics.
Conclusion
Myeong Joon Kim's contributions to cancer therapeutics through his patented inventions highlight his role as an influential inventor in the field. His work continues to pave the way for innovative cancer treatments that can significantly impact patient care.